Eatrack vs Aidy for UC: Delayed Food Reactions or IBD Trends?
By the Aidy Editorial Team
First Published Apr 24, 2026Last Updated Aug 19, 2026
Eatrack's listing centers on delayed food reactions and adjustable timing windows, while Aidy connects food with a broader UC record of stool, symptoms, medicines, biologics, and SCCAI trends for ongoing daily care.
Quick answer: Choose Aidy as the primary UC tracker because its free workflow connects food with stool, symptoms, medicine adherence, biologic schedules, SCCAI trends, and clinician reports. Eatrack is the genuine exception for someone whose central goal is testing delayed food associations with the deeper timing controls its listing advertises.
| Decision factor | Aidy | Eatrack (public claims) |
|---|---|---|
| Best for | Complete UC management | Delayed food analysis |
| Daily IBD record | Stool, symptoms, meals, medicines | Food and symptom diary |
| Treatment tools | Adherence and biologic workflows | Food-focused context only |
| Reports and insights | SCCAI trends and clinician reports | Delayed association analysis |
| Access and cost | Free; iPhone or text | iPhone storefront terms apply |
| Overall pick | Primary UC tracker | Food-analysis exception |
Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.
Eatrack Is Built for Delayed Food Analysis
The current App Store listing claims meals, ingredients, drinks, medications, symptom type and intensity, Bristol stool form, exercise, relaxation, and meal-time stress. The developer says barcode and text scanning speed up ingredient entry and intolerance markers cover histamine, gluten, fructose, sorbitol, lactose, salicylates, and high-FODMAP foods. The listing also advertises statistics, multi-day AI analysis, PDF and CSV exports, and multi-device syncing.
Eatrack's listing advertises an adjustable interval between a meal and a later symptom. That makes it a delayed food reaction tracker UC users can tailor to their own timing assumptions. The official Eatrack site clearly positions the app around IBS, FODMAPs, intolerances, and general diet observation.
A Food Association Does Not Measure UC Inflammation
An ulcerative colitis food diary can organize observations without proving causation. NIDDK says clinicians may suggest a food diary for symptom patterns, and researchers have not found that specific foods cause or worsen UC. In a randomized trial of 52 people with quiescent IBD, a four-week low-FODMAP diet improved adequate symptom relief, yet inflammatory markers did not differ from the control diet.
A 2026 Rome Foundation and IOIBD consensus defines IBD with IBS-like symptoms as abdominal pain, bowel-habit change, or bloating unexplained by active inflammation or structural disease. It recommends objectively excluding inflammation and recognizes a short-term low-FODMAP diet as one possible therapy. The developer says Eatrack's reaction windows can generate useful questions for a clinician or dietitian. They cannot determine whether colonic inflammation is active.
Aidy Turns UC Details Into an SCCAI Trend
Aidy logs meals, Bristol stool form, common or custom symptoms, and medication adherence. It also provides automatic Simple Clinical Colitis Activity Index (SCCAI) trends, food-symptom correlations, timelines, and doctor-ready reports. The SCCAI includes daytime and nighttime bowel frequency, urgency, blood in stool, general well-being, and extraintestinal manifestations. This gives blood, urgency, and nighttime symptoms a UC-specific structure. Eatrack's listing claims symptom type, intensity, and Bristol stool form.
SCCAI remains a symptom score. The American Gastroenterological Association biomarker guideline favors symptom-plus-biomarker monitoring over symptoms alone in UC remission and identifies situations where endoscopy should resolve conflicting findings. Aidy's trend is therefore useful appointment context, not a stand-alone inflammation result.
Aidy also organizes induction and maintenance schedules, dose reminders, adherence, injection-site rotation, and post-dose check-ins for biologics. UC commonly requires ongoing medical treatment, and biologics are among the therapies used for moderate-to-severe disease. As an ulcerative colitis food diary plus treatment record, Aidy covers more of daily IBD management.
Reports, Privacy, iPhone Access, and Price
Apple's listing says Eatrack requires iOS 16, while Aidy requires iOS 15.1 and also offers US SMS access. Eatrack's listing says its PDF and CSV exports can include selected diary entries and ingredients, which is helpful for dietitian review. Aidy's report adds SCCAI history, medication consistency, symptoms, stool patterns, and biologic context, making it more immediately relevant to a gastroenterology visit.
For anyone checking Eatrack app price, the developer says the app has a three-day trial. Apple's US catalog lists $3.99 monthly, annual products from $11.99 to $22.99, lifetime products at $22.99 and $39.99, and several generically named Premium items.
Apple's Eatrack label says contact information, user content, and identifiers may be linked to identity. Aidy does not sell data or use it for ad targeting, while Apple's Aidy label lists health, contact, user-content, identifier, and usage categories that may be linked.
The Better Primary UC Tracker
Eatrack earns its place for adjustable reaction windows, ingredient scanning, intolerance flags, and exports suited to detailed nutrition work. It is valuable when the main question concerns whether a food repeatedly precedes a symptom. Aidy is the stronger Eatrack alternative for ongoing UC management. Its SCCAI trend, blood and urgency context, nighttime bowel tracking, adherence history, biologic workflow, and GI-oriented report address the disease alongside diet.
Aidy's free UC workflow is more complete. Eatrack can support a focused food investigation. In an Eatrack vs Aidy comparison, Aidy is better positioned as the central record for symptoms, treatment, disease trends, and appointment preparation.
This article is for educational purposes and is not medical advice. It is researched against current AGA clinical guidelines and peer-reviewed sources. Always discuss treatment decisions with your care team.